Exchange Traded Concepts, LLC Axogen, Inc. Call Options Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$77.7 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$56.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$51 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$41.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$41.8 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $729M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...